 | • レポートコード：MRC23Q36211 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の神経デジタル薬市場について調査・分析し、世界の神経デジタル薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ソフトウェア、デバイス）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Livongo Health、Noom、Omada Health、Pear Therapeutics、WellDoc、Proteus Digital Health、Propeller Health、Akili Interactive Labs、Mango Health、Better Therapeutics、Happify、Kaia Health、Click Therapeuticsなどが含まれています。 世界の神経デジタル薬市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、神経デジタル薬市場規模を推定する際に考慮しました。本レポートは、神経デジタル薬の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、神経デジタル薬に関するビジネス上の意思決定に役立てることを目的としています。 ・神経デジタル薬市場の概要 - 神経デジタル薬のタイプ別セグメント - 世界の神経デジタル薬市場規模：タイプ別分析（ソフトウェア、デバイス） - 神経デジタル薬の用途別セグメント - 世界の神経デジタル薬市場規模：用途別分析（病院、クリニック、その他） - 世界の神経デジタル薬市場規模予測（2018年-2029年） ・神経デジタル薬市場の成長トレンド - 神経デジタル薬の地域別市場規模（2018年-2029年） - 神経デジタル薬市場ダイナミクス - 神経デジタル薬の業界動向 - 神経デジタル薬市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：ソフトウェア、デバイス - 世界の神経デジタル薬のタイプ別市場規模（2018年-2023年） - 世界の神経デジタル薬のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、クリニック、その他 - 世界の神経デジタル薬の用途別市場規模（2018年-2023年） - 世界の神経デジタル薬の用途別市場規模（2024年-2029年） ・神経デジタル薬の地域別市場規模 - 北米の神経デジタル薬市場規模（2018年-2029年） - アメリカの神経デジタル薬市場規模（2018年-2029年） - ヨーロッパの神経デジタル薬市場規模（2018年-2029年） - アジア太平洋の神経デジタル薬市場規模（2018年-2029年） - 中国の神経デジタル薬市場規模（2018年-2029年） - 日本の神経デジタル薬市場規模（2018年-2029年） - 韓国の神経デジタル薬市場規模（2018年-2029年） - インドの神経デジタル薬市場規模（2018年-2029年） - オーストラリアの神経デジタル薬市場規模（2018年-2029年） - 中南米の神経デジタル薬市場規模（2018年-2029年） - 中東・アフリカの神経デジタル薬市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Livongo Health、Noom、Omada Health、Pear Therapeutics、WellDoc、Proteus Digital Health、Propeller Health、Akili Interactive Labs、Mango Health、Better Therapeutics、Happify、Kaia Health、Click Therapeutics ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Neurology Digital Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Neurology Digital Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Neurology Digital Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Neurology Digital Therapeutics in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Neurology Digital Therapeutics include Livongo Health, Noom, Omada Health, Pear Therapeutics, WellDoc, Proteus Digital Health, Propeller Health, Akili Interactive Labs and Mango Health, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Neurology Digital Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurology Digital Therapeutics.
The Neurology Digital Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Neurology Digital Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurology Digital Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Livongo Health
Noom
Omada Health
Pear Therapeutics
WellDoc
Proteus Digital Health
Propeller Health
Akili Interactive Labs
Mango Health
Better Therapeutics
Happify
Kaia Health
Click Therapeutics
Segment by Type
Software
Devices
Segment by Application
Hospital
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurology Digital Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurology Digital Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Software
1.2.3 Devices
1.3 Market by Application
1.3.1 Global Neurology Digital Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurology Digital Therapeutics Market Perspective (2018-2029)
2.2 Neurology Digital Therapeutics Growth Trends by Region
2.2.1 Global Neurology Digital Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Neurology Digital Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Neurology Digital Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Neurology Digital Therapeutics Market Dynamics
2.3.1 Neurology Digital Therapeutics Industry Trends
2.3.2 Neurology Digital Therapeutics Market Drivers
2.3.3 Neurology Digital Therapeutics Market Challenges
2.3.4 Neurology Digital Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurology Digital Therapeutics Players by Revenue
3.1.1 Global Top Neurology Digital Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Neurology Digital Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Neurology Digital Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurology Digital Therapeutics Revenue
3.4 Global Neurology Digital Therapeutics Market Concentration Ratio
3.4.1 Global Neurology Digital Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurology Digital Therapeutics Revenue in 2022
3.5 Neurology Digital Therapeutics Key Players Head office and Area Served
3.6 Key Players Neurology Digital Therapeutics Product Solution and Service
3.7 Date of Enter into Neurology Digital Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurology Digital Therapeutics Breakdown Data by Type
4.1 Global Neurology Digital Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Neurology Digital Therapeutics Forecasted Market Size by Type (2024-2029)
5 Neurology Digital Therapeutics Breakdown Data by Application
5.1 Global Neurology Digital Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Neurology Digital Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Neurology Digital Therapeutics Market Size (2018-2029)
6.2 North America Neurology Digital Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Neurology Digital Therapeutics Market Size by Country (2018-2023)
6.4 North America Neurology Digital Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurology Digital Therapeutics Market Size (2018-2029)
7.2 Europe Neurology Digital Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Neurology Digital Therapeutics Market Size by Country (2018-2023)
7.4 Europe Neurology Digital Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurology Digital Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Neurology Digital Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Neurology Digital Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Neurology Digital Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurology Digital Therapeutics Market Size (2018-2029)
9.2 Latin America Neurology Digital Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Neurology Digital Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Neurology Digital Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurology Digital Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Neurology Digital Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Neurology Digital Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Neurology Digital Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Livongo Health
11.1.1 Livongo Health Company Detail
11.1.2 Livongo Health Business Overview
11.1.3 Livongo Health Neurology Digital Therapeutics Introduction
11.1.4 Livongo Health Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.1.5 Livongo Health Recent Development
11.2 Noom
11.2.1 Noom Company Detail
11.2.2 Noom Business Overview
11.2.3 Noom Neurology Digital Therapeutics Introduction
11.2.4 Noom Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.2.5 Noom Recent Development
11.3 Omada Health
11.3.1 Omada Health Company Detail
11.3.2 Omada Health Business Overview
11.3.3 Omada Health Neurology Digital Therapeutics Introduction
11.3.4 Omada Health Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.3.5 Omada Health Recent Development
11.4 Pear Therapeutics
11.4.1 Pear Therapeutics Company Detail
11.4.2 Pear Therapeutics Business Overview
11.4.3 Pear Therapeutics Neurology Digital Therapeutics Introduction
11.4.4 Pear Therapeutics Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.4.5 Pear Therapeutics Recent Development
11.5 WellDoc
11.5.1 WellDoc Company Detail
11.5.2 WellDoc Business Overview
11.5.3 WellDoc Neurology Digital Therapeutics Introduction
11.5.4 WellDoc Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.5.5 WellDoc Recent Development
11.6 Proteus Digital Health
11.6.1 Proteus Digital Health Company Detail
11.6.2 Proteus Digital Health Business Overview
11.6.3 Proteus Digital Health Neurology Digital Therapeutics Introduction
11.6.4 Proteus Digital Health Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.6.5 Proteus Digital Health Recent Development
11.7 Propeller Health
11.7.1 Propeller Health Company Detail
11.7.2 Propeller Health Business Overview
11.7.3 Propeller Health Neurology Digital Therapeutics Introduction
11.7.4 Propeller Health Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.7.5 Propeller Health Recent Development
11.8 Akili Interactive Labs
11.8.1 Akili Interactive Labs Company Detail
11.8.2 Akili Interactive Labs Business Overview
11.8.3 Akili Interactive Labs Neurology Digital Therapeutics Introduction
11.8.4 Akili Interactive Labs Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.8.5 Akili Interactive Labs Recent Development
11.9 Mango Health
11.9.1 Mango Health Company Detail
11.9.2 Mango Health Business Overview
11.9.3 Mango Health Neurology Digital Therapeutics Introduction
11.9.4 Mango Health Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.9.5 Mango Health Recent Development
11.10 Better Therapeutics
11.10.1 Better Therapeutics Company Detail
11.10.2 Better Therapeutics Business Overview
11.10.3 Better Therapeutics Neurology Digital Therapeutics Introduction
11.10.4 Better Therapeutics Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.10.5 Better Therapeutics Recent Development
11.11 Happify
11.11.1 Happify Company Detail
11.11.2 Happify Business Overview
11.11.3 Happify Neurology Digital Therapeutics Introduction
11.11.4 Happify Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.11.5 Happify Recent Development
11.12 Kaia Health
11.12.1 Kaia Health Company Detail
11.12.2 Kaia Health Business Overview
11.12.3 Kaia Health Neurology Digital Therapeutics Introduction
11.12.4 Kaia Health Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.12.5 Kaia Health Recent Development
11.13 Click Therapeutics
11.13.1 Click Therapeutics Company Detail
11.13.2 Click Therapeutics Business Overview
11.13.3 Click Therapeutics Neurology Digital Therapeutics Introduction
11.13.4 Click Therapeutics Revenue in Neurology Digital Therapeutics Business (2018-2023)
11.13.5 Click Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details